3.0.0 4535 2022-12-29T18:33:45Z 2022-12-29T18:33:45Z Senate S 2022-07-14 117 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2022-07-14T17:03:28Z Food and Drug Amendments of 2022 117 7667 HR 2022-06-09 Received in the Senate. Related bill CRS FDASLA Act of 2022 117 4348 S 2022-07-13 Placed on Senate Legislative Calendar under General Orders. Calendar No. 444. Related bill CRS Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 117 6833 HR 2022-09-30 Became Public Law No: 117-180. Related bill CRS 2022-07-14 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2022-07-14 Introduced in Senate IntroReferral 10000 9 Library of Congress B001135 Sen. Burr, Richard [R-NC] Richard Burr R NC Mauze N Health Health 00 2022-07-14 Introduced in Senate 2022-11-21T16:12:49Z Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022

This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

]]> FDASRA Act of 2022 Display Title FDASRA Act of 2022 Short Title(s) as Introduced FDASRA Act of 2022 Introduced in Senate IS Short Title(s) as Introduced Food and Drug Administration Simple Reauthorization Act of 2022 Introduced in Senate IS Short Title(s) as Introduced for portions of this bill Biosimilar User Fee Amendments of 2022 Introduced in Senate IS Short Title(s) as Introduced for portions of this bill Generic Drug User Fee Amendments of 2022 Introduced in Senate IS Short Title(s) as Introduced for portions of this bill Medical Device User Fee Amendments of 2022 Introduced in Senate IS Short Title(s) as Introduced for portions of this bill Prescription Drug User Fee Amendments of 2022 Introduced in Senate IS Official Title as Introduced A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes. Introduced in Senate IS Introduced in Senate 2022-07-14T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-117s4535is/xml/BILLS-117s4535is.xml 2022-07-14 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.